ArticleInternational journal of clinical pharmacy2026
Beyond scope of practice: a prescribing autonomy framework to support early-career prescribers.
Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The introduction of pharmacist independent prescribing at the point of registration represents a profound shift in UK pharmacy practice. From 2026, newly qualified pharmacist independent prescribers will begin their careers with prescribing responsibilities but without the experiential consolidation or structured supervision pathways that underpin early prescribing in other professions. Existing governance mechanisms-particularly the concept of scope of practice-were designed for experienced, often specialist, prescribers and therefore fail to capture the dynamic decision-support needs of novice practitioners working across varied clinical contexts. Competency frameworks also provide limited insight into how prescribers negotiate uncertainty, collaborate with colleagues or calibrate clinical oversight in day-to-day practice. This commentary argues that these developments in the UK require an alternative approach to describing, governing and supporting prescribing practice, particularly at transition points. The Prescribing Autonomy Framework (PAF) proposes a context-sensitive framework that categorises prescribing decision-making into three levels of autonomy-low, medium and high-based on the degree of collaboration, protocol use, clinical oversight and digital decision-support required. By focusing on how prescribing decisions are reached rather than solely on what prescribers are authorised to prescribe, the framework offers a structured vocabulary for framing competence, informing support needs and surfacing risks. It also intersects with concepts of clinical complexity, accountability and risk, with the potential to support richer reflection and governance than existing approaches in the UK. While developed in response to changes in UK pharmacy training, the framework may have broader applicability. It offers a mechanism for supporting early-career prescribers across professions, guiding transitions into new areas of practice and strengthening healthcare governance. As prescribing roles expand internationally, the PAF aims to provide a scalable and adaptable approach to supporting safe, contextualised development of prescribing practice. The framework is presented as a theoretical governance lens and has not yet undergone empirical testing or formal validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.